nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—PTGS2—bile duct cancer	0.986	1	CbGaD
Meclofenamic acid—Acetylsalicylic acid—TP53—bile duct cancer	0.00537	0.436	CrCbGaD
Meclofenamic acid—Lumiracoxib—PTGS2—bile duct cancer	0.00178	0.144	CrCbGaD
Meclofenamic acid—Salsalate—PTGS2—bile duct cancer	0.0014	0.114	CrCbGaD
Meclofenamic acid—Mefenamic acid—PTGS2—bile duct cancer	0.00108	0.0875	CrCbGaD
Meclofenamic acid—Acetylsalicylic acid—PTGS2—bile duct cancer	0.00105	0.0852	CrCbGaD
Meclofenamic acid—Salicylic acid—PTGS2—bile duct cancer	0.000864	0.0702	CrCbGaD
Meclofenamic acid—Diclofenac—PTGS2—bile duct cancer	0.000774	0.0628	CrCbGaD
Meclofenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—bile duct cancer	0.0001	0.0602	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bile duct cancer	8.75e-05	0.0524	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—ROBO2—bile duct cancer	6.7e-05	0.0402	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—ROBO2—bile duct cancer	6.7e-05	0.0402	CbGpPWpGaD
Meclofenamic acid—ALOX5—Eicosanoid Synthesis—PTGS2—bile duct cancer	5.71e-05	0.0342	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—ROBO2—bile duct cancer	4.78e-05	0.0287	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—ROBO2—bile duct cancer	4.78e-05	0.0287	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	3.92e-05	0.0235	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	3.91e-05	0.0234	CbGpPWpGaD
Meclofenamic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bile duct cancer	3.81e-05	0.0228	CbGpPWpGaD
Meclofenamic acid—ALOX5—Arachidonic acid metabolism—PTGS2—bile duct cancer	3.17e-05	0.019	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Arachidonic acid metabolism—PTGS2—bile duct cancer	3.16e-05	0.0189	CbGpPWpGaD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—PTGS2—bile duct cancer	2.98e-05	0.0179	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	2.6e-05	0.0156	CbGpPWpGaD
Meclofenamic acid—PTGS1—Eicosanoid Synthesis—PTGS2—bile duct cancer	2.48e-05	0.0148	CbGpPWpGaD
Meclofenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bile duct cancer	2.07e-05	0.0124	CbGpPWpGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—PTGS2—bile duct cancer	2.02e-05	0.0121	CbGpPWpGaD
Meclofenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—bile duct cancer	1.98e-05	0.0118	CbGpPWpGaD
Meclofenamic acid—KCNQ3—L1CAM interactions—EGFR—bile duct cancer	1.92e-05	0.0115	CbGpPWpGaD
Meclofenamic acid—KCNQ2—L1CAM interactions—EGFR—bile duct cancer	1.92e-05	0.0115	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—FAR2—bile duct cancer	1.75e-05	0.0105	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—FAR2—bile duct cancer	1.74e-05	0.0104	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	1.7e-05	0.0102	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	1.65e-05	0.00987	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	1.64e-05	0.00983	CbGpPWpGaD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—IL6—bile duct cancer	1.63e-05	0.00974	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—MET—bile duct cancer	1.43e-05	0.00857	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—MET—bile duct cancer	1.43e-05	0.00857	CbGpPWpGaD
Meclofenamic acid—PTGS1—Arachidonic acid metabolism—PTGS2—bile duct cancer	1.38e-05	0.00824	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	1.35e-05	0.00809	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—SMAD4—bile duct cancer	1.33e-05	0.00799	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—SMAD4—bile duct cancer	1.33e-05	0.00799	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	1.32e-05	0.00793	CbGpPWpGaD
Meclofenamic acid—PTGS2—Overview of nanoparticle effects—IL6—bile duct cancer	1.29e-05	0.00773	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—MMP2—bile duct cancer	1.19e-05	0.00715	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—MMP2—bile duct cancer	1.19e-05	0.00715	CbGpPWpGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—IL6—bile duct cancer	1.1e-05	0.00659	CbGpPWpGaD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	1.09e-05	0.00653	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—ERBB2—bile duct cancer	1.05e-05	0.00626	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—ERBB2—bile duct cancer	1.05e-05	0.00626	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—GNAS—bile duct cancer	1.03e-05	0.00616	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—MET—bile duct cancer	1.02e-05	0.00612	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—MET—bile duct cancer	1.02e-05	0.00612	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—RNF43—bile duct cancer	1.01e-05	0.00608	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	9.08e-06	0.00544	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—MMP9—bile duct cancer	8.97e-06	0.00537	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—MMP9—bile duct cancer	8.97e-06	0.00537	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—PTGS2—bile duct cancer	8.75e-06	0.00524	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IDH1—bile duct cancer	8.73e-06	0.00523	CbGpPWpGaD
Meclofenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bile duct cancer	8.65e-06	0.00518	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—IDH2—bile duct cancer	8.53e-06	0.00511	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—MMP2—bile duct cancer	8.52e-06	0.0051	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—MMP2—bile duct cancer	8.52e-06	0.0051	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—IDH2—bile duct cancer	8.5e-06	0.00509	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	8.28e-06	0.00496	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—NRAS—bile duct cancer	7.96e-06	0.00477	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—NRAS—bile duct cancer	7.96e-06	0.00477	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	7.82e-06	0.00468	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—FAR2—bile duct cancer	7.57e-06	0.00454	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—NOS2—bile duct cancer	7.47e-06	0.00448	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—ERBB2—bile duct cancer	7.46e-06	0.00447	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—ERBB2—bile duct cancer	7.46e-06	0.00447	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—IDH1—bile duct cancer	7.34e-06	0.00439	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—IDH1—bile duct cancer	7.31e-06	0.00438	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—EGFR—bile duct cancer	7.25e-06	0.00434	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—EGFR—bile duct cancer	7.25e-06	0.00434	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	7.14e-06	0.00428	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RNF43—bile duct cancer	7.11e-06	0.00426	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—KRAS—bile duct cancer	6.85e-06	0.0041	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—KRAS—bile duct cancer	6.85e-06	0.0041	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	6.83e-06	0.00409	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	6.65e-06	0.00398	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Neuronal System—HRAS—bile duct cancer	6.56e-06	0.00393	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Neuronal System—HRAS—bile duct cancer	6.56e-06	0.00393	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—MMP9—bile duct cancer	6.4e-06	0.00383	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—MMP9—bile duct cancer	6.4e-06	0.00383	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—FAR2—bile duct cancer	6.01e-06	0.0036	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—HRAS—bile duct cancer	5.82e-06	0.00349	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—HRAS—bile duct cancer	5.82e-06	0.00349	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—NRAS—bile duct cancer	5.68e-06	0.0034	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—NRAS—bile duct cancer	5.68e-06	0.0034	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	5.67e-06	0.0034	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—NRAS—bile duct cancer	5.61e-06	0.00336	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—IL6—bile duct cancer	5.57e-06	0.00334	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—IL6—bile duct cancer	5.57e-06	0.00334	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	5.54e-06	0.00332	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—TGFB1—bile duct cancer	5.28e-06	0.00316	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—TGFB1—bile duct cancer	5.28e-06	0.00316	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—EGFR—bile duct cancer	5.17e-06	0.0031	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—EGFR—bile duct cancer	5.17e-06	0.0031	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—KRAS—bile duct cancer	4.89e-06	0.00293	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—KRAS—bile duct cancer	4.89e-06	0.00293	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—SLC5A5—bile duct cancer	4.84e-06	0.0029	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	4.83e-06	0.00289	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—SLC5A5—bile duct cancer	4.82e-06	0.00289	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	4.82e-06	0.00289	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—IL6—bile duct cancer	4.77e-06	0.00286	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TGFBR2—bile duct cancer	4.64e-06	0.00278	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.53e-06	0.00272	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.52e-06	0.00271	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SMAD4—bile duct cancer	4.39e-06	0.00263	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	4.3e-06	0.00258	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—HRAS—bile duct cancer	4.15e-06	0.00249	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—HRAS—bile duct cancer	4.15e-06	0.00249	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	4.11e-06	0.00246	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—IL6—bile duct cancer	3.98e-06	0.00238	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—IL6—bile duct cancer	3.98e-06	0.00238	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	3.97e-06	0.00238	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	3.9e-06	0.00233	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	3.82e-06	0.00229	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	3.79e-06	0.00227	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GNAS—bile duct cancer	3.76e-06	0.00225	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GNAS—bile duct cancer	3.75e-06	0.00224	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—IDH2—bile duct cancer	3.7e-06	0.00222	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RNF43—bile duct cancer	3.51e-06	0.0021	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	3.27e-06	0.00196	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NOS2—bile duct cancer	3.27e-06	0.00196	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TGFBR2—bile duct cancer	3.25e-06	0.00194	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—IDH1—bile duct cancer	3.18e-06	0.00191	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—GNAS—bile duct cancer	3.13e-06	0.00188	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SMAD4—bile duct cancer	3.07e-06	0.00184	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IDH1—bile duct cancer	3.02e-06	0.00181	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	2.99e-06	0.00179	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—IDH2—bile duct cancer	2.94e-06	0.00176	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	2.7e-06	0.00162	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	2.65e-06	0.00159	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—IDH1—bile duct cancer	2.53e-06	0.00151	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	2.5e-06	0.0015	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ERBB2—bile duct cancer	2.46e-06	0.00147	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTGS2—bile duct cancer	2.4e-06	0.00144	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	2.22e-06	0.00133	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC5A5—bile duct cancer	2.1e-06	0.00126	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS2—bile duct cancer	2.02e-06	0.00121	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS2—bile duct cancer	2.01e-06	0.00121	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.97e-06	0.00118	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NRAS—bile duct cancer	1.87e-06	0.00112	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TGFB1—bile duct cancer	1.74e-06	0.00104	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ERBB2—bile duct cancer	1.72e-06	0.00103	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EGFR—bile duct cancer	1.7e-06	0.00102	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC5A5—bile duct cancer	1.67e-06	0.000998	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GNAS—bile duct cancer	1.63e-06	0.000977	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—bile duct cancer	1.61e-06	0.000964	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFBR2—bile duct cancer	1.6e-06	0.00096	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SMAD4—bile duct cancer	1.52e-06	0.000908	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MMP9—bile duct cancer	1.48e-06	0.000884	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HRAS—bile duct cancer	1.37e-06	0.000819	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NRAS—bile duct cancer	1.31e-06	0.000784	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6—bile duct cancer	1.31e-06	0.000784	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GNAS—bile duct cancer	1.29e-06	0.000775	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TGFB1—bile duct cancer	1.22e-06	0.000729	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EGFR—bile duct cancer	1.19e-06	0.000714	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NOS2—bile duct cancer	1.13e-06	0.000676	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—bile duct cancer	1.13e-06	0.000675	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—bile duct cancer	1e-06	0.0006	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HRAS—bile duct cancer	9.58e-07	0.000574	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6—bile duct cancer	9.17e-07	0.000549	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTGS2—bile duct cancer	8.76e-07	0.000525	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB2—bile duct cancer	8.49e-07	0.000508	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NRAS—bile duct cancer	6.46e-07	0.000387	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TGFB1—bile duct cancer	6e-07	0.000359	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EGFR—bile duct cancer	5.88e-07	0.000352	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—bile duct cancer	5.56e-07	0.000333	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HRAS—bile duct cancer	4.73e-07	0.000283	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6—bile duct cancer	4.52e-07	0.000271	CbGpPWpGaD
